BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neyshaburinezhad N, Seidabadi M, Rouini M, Lavasani H, Foroumadi A, Ardakani YH. Evaluation of hepatic CYP2D1 activity and hepatic clearance in type I and type II diabetic rat models, before and after treatment with insulin and metformin. Daru 2020;28:479-87. [PMID: 32378154 DOI: 10.1007/s40199-020-00350-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Neyshaburinezhad N, Ghasim H, Rouini M, Daali Y, Ardakani YH. Frequency of Important CYP450 Enzyme Gene Polymorphisms in the Iranian Population in Comparison with Other Major Populations: A Comprehensive Review of the Human Data. J Pers Med 2021;11:804. [PMID: 34442448 DOI: 10.3390/jpm11080804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 Yadav J, El Hassani M, Sodhi J, Lauschke VM, Hartman JH, Russell LE. Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data. Drug Metab Rev 2021;53:207-33. [PMID: 33989099 DOI: 10.1080/03602532.2021.1922435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Neyshaburinezhad N, Rouini M, Lavasani H, H. Ardakani Y. Evaluation of Cinnamon (Cinnamomum Verum) Effects on Liver CYP450 2D1 Activity and Hepatic Clearance in Diabetic Rats. Jundishapur J Nat Pharm Prod 2021;16. [DOI: 10.5812/jjnpp.101797] [Reference Citation Analysis]
4 Rezai S, Neyshaburinezhad N, Rouini M, Lavasani H, H Ardakani Y. Can combination therapy with insulin and metformin improve metabolic function of the liver, in type I diabetic patients? An animal model study on CYP2D1 activity. J Diabetes Metab Disord 2020;19:2049-56. [PMID: 33520876 DOI: 10.1007/s40200-020-00678-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]